Hong Kong Outpatient AF Screening Using Single-lead ECG Device

NACompletedINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

January 1, 2015

Primary Completion Date

December 31, 2017

Study Completion Date

September 30, 2019

Conditions
Atrial Fibrillation
Interventions
OTHER

Patient education

(i) Patient education (ii) Assess individual risk of stroke using the CHADS2 and CHA2DS2VASc score and risk of major bleeding using the HAS-BLED score (iii) Recommendation of evidence-based stroke prevention therapy based on international guidelines (iv) Patient audit and follow-up (v) Patients not on appropriate OAC without adequate explanation will be referred to Cardiology Outpatient Clinic for second opinion

OTHER

Routine care

The iECG tracing and report is provided to the attending doctor. Prescription of OAC is left to the discretion of the attending doctor.

Trial Locations (1)

Unknown

Prince of Wales Hospital, Shatin

All Listed Sponsors
collaborator

University of Sydney

OTHER

lead

Chinese University of Hong Kong

OTHER

NCT02409654 - Hong Kong Outpatient AF Screening Using Single-lead ECG Device | Biotech Hunter | Biotech Hunter